207 related articles for article (PubMed ID: 32721657)
21. Quantitative fragmented QRS has a good diagnostic value on myocardial fibrosis in hypertrophic obstructive cardiomyopathy based on clinical-pathological study.
Bi X; Yang C; Song Y; Yuan J; Cui J; Hu F; Qiao S
BMC Cardiovasc Disord; 2020 Jun; 20(1):298. PubMed ID: 32552709
[TBL] [Abstract][Full Text] [Related]
22. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy.
Henein MY; O'Sullivan CA; Ramzy IS; Sigwart U; Gibson DG
J Am Coll Cardiol; 1999 Oct; 34(4):1117-22. PubMed ID: 10520800
[TBL] [Abstract][Full Text] [Related]
23. Large Q and S waves in lead III on the electrocardiogram distinguish patients with hypertrophic cardiomyopathy from athletes.
Chen AS; Bent RE; Wheeler M; Knowles JW; Haddad F; Froelicher V; Ashley E; Perez MV
Heart; 2018 Nov; 104(22):1871-1877. PubMed ID: 29680808
[TBL] [Abstract][Full Text] [Related]
24. [Cardiac changes induced by deconditioning in athletes: an echocardiographic and electrocardiographic study].
Petretta M; Cavallaro V; Bianchi V; La Mura G; Conforti G; Breglio R; Valva G; Morgano G; Bonaduce D
G Ital Cardiol; 1991 Nov; 21(11):1167-77. PubMed ID: 1809620
[TBL] [Abstract][Full Text] [Related]
25. Electro- and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy.
Bula K; Bisaga J; Feret B; Razik M; Rozpiątkowska B; Tometczak M; Mizia-Stec K
Ann Noninvasive Electrocardiol; 2022 Sep; 27(5):e12992. PubMed ID: 35855565
[TBL] [Abstract][Full Text] [Related]
26. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Veselka J; Honek T
Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
[TBL] [Abstract][Full Text] [Related]
27. New algorithm for the localization of accessory atrioventricular connections using a baseline electrocardiogram.
Fitzpatrick AP; Gonzales RP; Lesh MD; Modin GW; Lee RJ; Scheinman MM
J Am Coll Cardiol; 1994 Jan; 23(1):107-16. PubMed ID: 8277067
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy.
Dollar AL; Roberts WC
Am J Med; 1989 Oct; 87(4):377-81. PubMed ID: 2529761
[TBL] [Abstract][Full Text] [Related]
29. Comparison of usefulness of Sokolow and Cornell criteria for left ventricular hypertrophy in subjects aged <20 years versus >30 years.
Grossman A; Prokupetz A; Koren-Morag N; Grossman E; Shamiss A
Am J Cardiol; 2012 Aug; 110(3):440-4. PubMed ID: 22534054
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.
Li ZQ; Cheng TO; Zhang WW; Qiao SB; Zhao LY; Jin YZ; Guan RM; Liu L
Int J Cardiol; 2004 Feb; 93(2-3):197-202. PubMed ID: 14975547
[TBL] [Abstract][Full Text] [Related]
31. Two severe complications post-percutaneous intramyocardial septal radiofrequency ablation in a patient with failed alcohol septal ablation: pulseless electrical activity cardiac arrest and pericardial tamponade-a case report.
Shu T; Shen C; Chen X; Yu F
Eur Heart J Case Rep; 2023 Aug; 7(8):ytad371. PubMed ID: 37637089
[TBL] [Abstract][Full Text] [Related]
32. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
[TBL] [Abstract][Full Text] [Related]
33. Ventricular mass and electrocardiographic criteria of hypertrophy: evaluation of new score.
Mazzaro Cdo L; Costa Fde A; Bombig MT; Luna Filho B; Paola AA; Carvalho AC; Costa Wd; Fonseca FA; Póvoa RM
Arq Bras Cardiol; 2008 Apr; 90(4):227-31. PubMed ID: 18516381
[TBL] [Abstract][Full Text] [Related]
34. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
Kazmierczak J; Kornacewicz-Jach Z; Kisly M; Gil R; Wojtarowicz A
Heart; 1998 Sep; 80(3):257-62. PubMed ID: 9875085
[TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation.
Cooper RM; Shahzad A; Hasleton J; Digiovanni J; Hall MC; Todd DM; Modi S; Stables RH
Europace; 2016 Jan; 18(1):113-20. PubMed ID: 26541709
[TBL] [Abstract][Full Text] [Related]
36. [ECG features of hypertrophy in hypertrophic cardiomyopathy, with special reference to asymmetric septal hypertrophy].
Nishiyama S; Shiratori K; Nishimura S; Araki R; Takeda K; Nagasaki F; Nakanishi S; Yamaguchi H
J Cardiogr; 1983 Mar; 13(1):71-8. PubMed ID: 6685743
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of ECG to differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome.
Tao Y; Xu J; Bako SY; Yao X; Yang D
BMC Cardiovasc Disord; 2020 Jun; 20(1):306. PubMed ID: 32576233
[TBL] [Abstract][Full Text] [Related]
38. Interventricular Septal Hematoma Caused by Percutaneous Intramyocardial Septal Radiofrequency Ablation Successfully Treated With Coil Embolization.
Wu B; Zhou Y; Lu J; Cui Y; Zhou Z; Lin W; Ma L; Xie X; Guo X
JACC Cardiovasc Interv; 2023 Mar; 16(6):722-724. PubMed ID: 36609045
[No Abstract] [Full Text] [Related]
39. Prognostic Significance of Initial r-Wave in Leads V1 and aVR Before PTSMA in Patients with Hypertrophic Obstructive Cardiomyopathy.
Jiang X; Qiao S
Int J Gen Med; 2021; 14():9589-9598. PubMed ID: 34916839
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of estimated plasma volume for postoperative hypotension in percutaneous intramyocardial septal radiofrequency ablation treating for hypertrophic obstructive cardiomyopathy.
Shan B; Li J; Shi Z; Han C; Zhang J; Zhao J; Hu R; Liu L; Ta S
BMC Cardiovasc Disord; 2024 Mar; 24(1):177. PubMed ID: 38519968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
